Navigation Links
Sangamo BioSciences to Present at the UBS Global Life Sciences Conference
Date:9/19/2007

RICHMOND, Calif., Sept. 19 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo's president and chief executive officer, will provide an update on the progress of Sangamo's ZFP Therapeutic development programs and an overview of the company's business strategy at 3:00 pm (ET) on Wednesday, September 26, 2007 at the UBS 2007 Global Life Sciences Conference in New York.

The presentation will be webcast live and may be accessed via a link on the Sangamo BioSciences website in the Investor Relations section http://investor.sangamo.com/index.cfm under Events and Presentations. The presentation will be archived on the Sangamo website for two weeks after the event.

About Sangamo

Sangamo BioSciences, Inc. is focused on the research and development of novel DNA-binding proteins for therapeutic gene regulation and modification. The most advanced ZFP Therapeutic(TM) development program is currently in Phase 2 clinical trials for evaluation of safety and clinical effect in patients with diabetic neuropathy. Phase 1 clinical trials are ongoing to evaluate a ZFP Therapeutic for peripheral artery disease. Other therapeutic development programs are focused on cancer and HIV/AIDS, neuropathic pain, nerve regeneration, Parkinson's disease and monogenic diseases. Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs). By engineering ZFPs that recognize a specific DNA sequence Sangamo has created ZFP transcription factors (ZFP TF(TM)) that can control gene expression and, consequently, cell function. Sangamo is also d
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Perscitus Biosciences secures $250K Commerce loan
2. Wisconsin biosciences rise to the challenge
3. Quintessence Biosciences advances cancer drug
4. Quintessence Biosciences names new president
5. Caden Biosciences may signal critical mass
6. Wisconsin start up Primorigen Biosciences corrals out-of-state investment
7. WARF signs licensing pact with BD Biosciences
8. Fisher Biosciences contracts with Madison-based GenTel BioSurfaces
9. State awards QRG Biosciences development grant
10. EMD Biosciences partners with European biotech company
11. Quintessence Biosciences forms cancer therapeutic advisory board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... 2013  Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that ... Marcum LLP Microcap Conference, May 30, in New ... Lyons , CPA, Chief Financial Officer of Cleveland BioLabs, ... 30 at 1:30 p.m. Eastern Time.  A live and archived ... Investors page of the Cleveland BioLabs website at www.cbiolabs.com ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 Alton Housing Authority ... May 15, 2013 said that their presence has already ... bed bug sufferers avoid such big spending, My Cleaning Products ... inexpensively. , It was said in the report that to ... MCP related. Apart from that, its employees also attended a ...
(Date:5/22/2013)... 22, 2013  Moderna Therapeutics, the pioneering company developing ... enable the in vivo production of therapeutic ... will join Moderna in early July as its ... a proven leader in the design and implementation of ... discovery to translation, clinical operations and commercial preparedness. John ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Custom ... to reporting eLearning solution using Tin Can API ... dashboard tool. CLD is a leading developer of ... medical device companies worldwide. , Tin Can ... that helps learners and trainers more accurately measure ...
Breaking Biology Technology:Cleveland BioLabs to Present at Second Annual Marcum LLP Microcap Conference 2Bed Bugs Cost Alton Housing Authority $35,000; New Help, How to Kill Bed Bugs With Less Expense, Introduced by My Cleaning Products 2Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer 2Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer 3CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 2CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 3
... the State speech that is anything less than optimistic, and ... or Democrat, riding high in the polls or battling mediocre ... the State speech to inspire, cajole and sprinkle a few ... to the state was no exception. , ,But how ...
... a visit to Sheboygan that the region could be a ... on Madison and Milwaukee. , ,A professor at Lakeland College ... work in local biotechnology companies, if the jobs were available. ... find jobs elsewhere, is a concern across Wisconsin. , ,At ...
... retrospectively reviewing what happened to major pharma and biotech companies, including ... investor perspective as reflected in a stock price and resultant valuation ... look at and value the impact of our industry. One such ... Companies to Work For 2006 published on January 11th. ...
Cached Biology Technology:How's the State of the State? It depends on what numbers are crunched 2How's the State of the State? It depends on what numbers are crunched 3Biotech leads list of top U.S. companies to work for 2Biotech leads list of top U.S. companies to work for 3Biotech leads list of top U.S. companies to work for 4Biotech leads list of top U.S. companies to work for 5
(Date:5/21/2013)... American Chemical Society (ACS), the world,s largest scientific ... National Meeting & Exposition, September 8-12, 2013, in ... Indiana Convention Center and at area hotels. , ... that span science,s horizons from astronomy to ... and online journalists a rich assortment of spot ...
(Date:5/21/2013)... largest gathering of biomass experts , Where? ... When? 03-07 June 2013 , ... research, resource assessment, market and policy developments, manufacturing and ... world and benefiting from its 2013 edition from a ... than 60 countries, more than 240 plenary and oral ...
(Date:5/21/2013)... 21, 2013 Royal Philips Electronics (NYSE: PHG, ... first portable ultrasound with Philips, industry leading Live 3D ... CX50 xMATRIX with available Live 3D TEE and ICE ... at the EuroPCR, official meeting for the European Association ... Since its launch in 2012, Philips CX50 xMATRIX has ...
Breaking Biology News(10 mins):21st European Biomass Conference and Exhibition 221st European Biomass Conference and Exhibition 321st European Biomass Conference and Exhibition 4Philips CX50 xMATRIX now offers world-class interventional and diagnostic features on single portable system 2
... Rochelle, NY, March 4, 2009--The disposable bioprocessing market ... preparation toward a range of products for cell ... Genetic Engineering & Biotechnology News (GEN). Increasing ... completely disposable bioprocess stream is feasible and even ...
... that dramatically strengthens stem cells, ability to regenerate damaged ... diseases such as myopathy and muscular dystrophy, according to ... The world-first procedure has been successfully used to ... be applied to all tissue-based illnesses in humans such ...
... athletes suddenly collapse, it can be due to hereditary cardiac ... a genetic modification that leads to cardiac weakness in an ... a heart condition. Since the fish have a genetic makeup ... for humans as well. Cardiac insufficiency is ...
Cached Biology News:GEN reports biomanufacturers target a fully disposable process stream 2Stem cell breakthrough gives new hope to sufferers of muscle-wasting diseases 2Why 'lazy Susan' has a weak heart 2
...
... is obtained from non-demolished blood ... fasted donors. The donors are ... and are maintained on an ... Protein Concentration : 85 mg/ml ...
Hamster serum...
... Filter Plates are offered in several versions. ... depth filter plates are ideal to prepare ... is simple, versatile, and necessary to prevent ... 10 um glass fiber and 20 um ...
Biology Products: